RSV Risks for Older Kiwis
New data shows a concerning trend in hospital admissions in Auckland for acute respiratory diseases, with a 13 per cent increase compared to last year. Health experts are urging older Kiwis to be vigilant this winter, as respiratory diseases such as influenza, Covid-19, and respiratory syncytial virus (RSV) are on the rise. RSV, in particular, is a highly contagious respiratory virus that poses a significant risk to older adults, especially those with existing respiratory conditions. Māori, Pasifika, and individuals in lower socioeconomic areas are also at higher risk of hospitalization from RSV. Experts are concerned that a combination of respiratory illnesses, including influenza, could lead to a surge in hospital admissions over the winter months.
Preventing RSV Infections
Immunologists and medical experts emphasize the importance of protecting older adults and individuals with chronic medical conditions against RSV. While RSV is often associated with young children, older adults are equally vulnerable to severe complications. Vaccination is a crucial preventive measure against RSV, with the world’s first RSV vaccine, Arexvy, now available for older adults in New Zealand. Research shows that the vaccine has an efficacy of 82.6 per cent against RSV-Lower Respiratory Tract Disease (LRTD), providing a vital layer of protection for at-risk populations. With RSV infections following a seasonal pattern and peaking during winter, timely vaccination and vigilance are key to reducing the impact of the virus on vulnerable individuals.
Public Health Measures and Awareness
Health authorities stress the importance of recognizing the symptoms of RSV, which can initially mimic a common cold but progress to more severe respiratory complications. Monitoring symptoms such as shortness of breath, wheezing, fever, and worsening cough is crucial, especially for older adults and individuals with compromised immune systems. Improved national surveillance of RSV through public health data can enhance early detection and response strategies, minimizing the spread of the virus in communities. By treating RSV with the same seriousness as Covid-19 and influenza, health experts aim to raise awareness and prevent the undue burden of hospitalizations and severe outcomes associated with the virus. Stay informed, stay protected, and prioritize your respiratory health this winter to safeguard against RSV risks.
